Redmile Group LLC 13D and 13G filings for REGENXBIO Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-11-14 9:00 pm Purchase | 2024-09-30 | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 4,942,312 9.900% | 1,181,622 (+31.42%) | Filing |
2024-02-14 4:26 pm Sale | 2023-12-31 | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 3,760,690 8.600% | -477,622 (-11.27%) | Filing |
2023-11-17 5:15 pm Purchase | 2023-11-09 | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 4,238,312 9.600% | 2,341,089 (+123.40%) | Filing |
2022-02-14 5:07 pm Sale | 2021-12-31 | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 1,897,223 4.400% | -226,269 (-10.66%) | Filing |
2021-02-16 4:08 pm Sale | 2020-12-31 | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 2,123,492 5.700% | -384,894 (-15.34%) | Filing |
2020-02-14 4:25 pm Purchase | 2019-12-31 | 13G | REGENXBIO Inc. RGNX | Redmile Group LLC | 2,508,386 6.800% | 2,508,386 (New Position) | Filing |